Heyman Richard A.
Director
CIK: 1584759
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 1,230 | $26.18 | $32,196.36 | View Details Filing |
| Feb 12, 2026 | Enliven Therapeutics, Inc. (ELVN) | A | 19,234 | $0.00 | $0.00 | View Details Filing |
| Jan 20, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 512 | $26.46 | $13,547.11 | View Details Filing |
| Jan 20, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 718 | $26.96 | $19,354.41 | View Details Filing |
| Jan 16, 2026 | ORIC Pharmaceuticals, Inc. (ORIC) | S | 3,500 | $12.00 | $42,016.10 | View Details Filing |
| Jan 16, 2026 | ORIC Pharmaceuticals, Inc. (ORIC) | S | 3,200 | $12.00 | $38,414.72 | View Details Filing |
| Jan 9, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 4,285 | $25.00 | $107,125.43 | View Details Filing |
| Jan 8, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 1,620 | $25.00 | $40,500.00 | View Details Filing |
| Jan 8, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 8,015 | $25.04 | $200,655.52 | View Details Filing |
| Jan 2, 2026 | ORIC Pharmaceuticals, Inc. (ORIC) | A | 40,000 | $0.00 | $0.00 | View Details Filing |